{"component": "definition", "props": {"groups": [{"snippet": "shall exist in the event that Purchaser, itself or through one or more of its Affiliates, licensees and sublicensees, (i) fails to satisfy the NDA Requirement, or (ii) in the reasonable judgment of APIL, fails to comply with its Commercially Reasonable Efforts requirements under Section 3.1 of this Exhibit D; provided that, any such failure is not attributable to the material breach by APIL or any of its Affiliates of any of the Ancillary Agreements, which material breach was noticed by Purchaser prior to its receipt of a Reversion Notice from APIL under this Section 4.1.\n(A) In the event the failure to satisfy the NDA Requirement is the result of a change in the FDA\u2019s policies or procedures regarding the approval of the Earn-Out Product or drugs in the same class as the Earn-Out Product, and Purchaser, its Affiliates, licensees or sublicensees have used Commercially Reasonable Efforts to accommodate such change and were still unable to satisfy the NDA Requirement, then the deadline shall be extended for a reasonable period of time, but not more than three-hundred sixty-five (365) calendar days or such longer period of time as determined by APIL in good faith based on the impact of such change in the FDA\u2019s policies or procedures on their ability to accommodate such change in policies or procedures.\n(B) In the event the failure to satisfy the NDA Requirement is the result of other delays or circumstances that are outside of the reasonable control of Purchaser or its Affiliates, licensees and sublicensees, and Purchaser, its Affiliates, licensees or sublicensees have used Commercially Reasonable Efforts consistent with Section 3.1 of this Exhibit D to overcome such delay or circumstance, then APIL will reasonably consider extending the deadline for a reasonable period of time, but not more than three-hundred sixty-five (365) days, to overcome such failure. In each case of (A) or (B), the compliance with such new deadline shall remain an obligation of Purchaser, its Affiliates, licensees or sublicensees subject to their diligence efforts under Section 3.1 of this Exhibit D and APIL\u2019s rights under this Section 4.1(a).", "size": 5, "samples": [{"hash": "11fbONJ9KRI", "uri": "/contracts/11fbONJ9KRI#reversion-event", "label": "Asset Transfer and License Agreement (Baudax Bio, Inc.)", "score": 30.7631759644, "published": true}, {"hash": "adPY7DuAFYV", "uri": "/contracts/adPY7DuAFYV#reversion-event", "label": "Asset Transfer and License Agreement (Recro Pharma, Inc.)", "score": 26.3579730988, "published": true}], "snippet_links": [{"key": "licensees-and-sublicensees", "type": "clause", "offset": [90, 116]}, {"key": "comply-with", "type": "definition", "offset": [213, 224]}, {"key": "commercially-reasonable-efforts", "type": "clause", "offset": [229, 260]}, {"key": "section-31", "type": "definition", "offset": [280, 291]}, {"key": "exhibit-d", "type": "definition", "offset": [300, 309]}, {"key": "provided-that", "type": "definition", "offset": [311, 324]}, {"key": "breach-by", "type": "clause", "offset": [379, 388]}, {"key": "ancillary-agreements", "type": "clause", "offset": [433, 453]}, {"key": "by-purchaser", "type": "clause", "offset": [489, 501]}, {"key": "prior-to", "type": "definition", "offset": [502, 510]}, {"key": "receipt-of-a", "type": "clause", "offset": [515, 527]}, {"key": "reversion-notice", "type": "definition", "offset": [528, 544]}, {"key": "section-41", "type": "clause", "offset": [566, 577]}, {"key": "in-the-event-the", "type": "clause", "offset": [583, 599]}, {"key": "failure-to-satisfy", "type": "clause", "offset": [600, 618]}, {"key": "a-change-in", "type": "definition", "offset": [656, 667]}, {"key": "the-fda", "type": "clause", "offset": [668, 675]}, {"key": "approval-of", "type": "clause", "offset": [715, 726]}, {"key": "the-earn", "type": "clause", "offset": [727, 735]}, {"key": "in-the-same-class", "type": "clause", "offset": [757, 774]}, {"key": "used-commercially", "type": "definition", "offset": [862, 879]}, {"key": "reasonable-period-of-time", "type": "definition", "offset": [1022, 1047]}, {"key": "calendar-days", "type": "clause", "offset": [1098, 1111]}, {"key": "in-good-faith", "type": "definition", "offset": [1164, 1177]}, {"key": "based-on", "type": "definition", "offset": [1178, 1186]}, {"key": "ability-to", "type": "definition", "offset": [1258, 1268]}, {"key": "change-in-policies", "type": "clause", "offset": [1286, 1304]}, {"key": "other-delays", "type": "clause", "offset": [1397, 1409]}, {"key": "control-of", "type": "definition", "offset": [1462, 1472]}, {"key": "consistent-with-section", "type": "clause", "offset": [1629, 1652]}, {"key": "each-case", "type": "definition", "offset": [1890, 1899]}, {"key": "compliance-with", "type": "definition", "offset": [1919, 1934]}, {"key": "obligation-of-purchaser", "type": "clause", "offset": [1969, 1992]}, {"key": "subject-to", "type": "clause", "offset": [2036, 2046]}, {"key": "diligence-efforts", "type": "clause", "offset": [2053, 2070]}, {"key": "rights-under-this-section", "type": "clause", "offset": [2118, 2143]}], "hash": "78a77f42cc71407a602e0a6424cde30a", "id": 1}, {"snippet": "Section 3.3(a)(i)", "size": 3, "samples": [{"hash": "compyo5epcK", "uri": "/contracts/compyo5epcK#reversion-event", "label": "Voting Agreement (Sohu Com Inc)", "score": 28.8384666443, "published": true}, {"hash": "9RN56FmqRhh", "uri": "/contracts/9RN56FmqRhh#reversion-event", "label": "Voting Agreement (Sogou Inc.)", "score": 28.7809715271, "published": true}, {"hash": "gbKEuvr93eR", "uri": "/contracts/gbKEuvr93eR#reversion-event", "label": "Voting Agreement (Sogou Inc.)", "score": 28.6167011261, "published": true}], "snippet_links": [], "hash": "f7d914222d9dd4f78bc0a0525a6741f1", "id": 2}, {"snippet": "means any or all of the following events:", "size": 3, "samples": [{"hash": "gpzoX91hVn3", "uri": "/contracts/gpzoX91hVn3#reversion-event", "label": "Executive Employment Agreement (Vizacom Inc)", "score": 16.0, "published": true}, {"hash": "e1c1Fp12cMF", "uri": "/contracts/e1c1Fp12cMF#reversion-event", "label": "Executive Employment Agreement (Vizacom Inc)", "score": 16.0, "published": true}, {"hash": "1MMHgklo8je", "uri": "/contracts/1MMHgklo8je#reversion-event", "label": "Agreement and Plan of Merger (Vizacom Inc)", "score": 16.0, "published": true}], "snippet_links": [], "hash": "1fd8d9e7d96b2939ed3df0c1c0a611ee", "id": 3}, {"snippet": "means the occurrence of any one or more of the following after the closing of the purchase of the Property upon a REIT Option Event or, in the event of a transfer of the Option to a Permitted Transferee, upon the giving of notice pursuant to Section 33.06(b) and prior to an IPO: (1) the contemplated REIT fails to sell common shares of the REIT to the public in an IPO before the earlier to occur of the one- year anniversary of the closing of the purchase transaction or the August 15 occurring immediately subsequent to the calendar year in which the purchase of the Property is closed; (2) either \u2587\u2587\u2587\u2587\u2587\u2587 or its Affiliates fail to own or control the Tenant in proportions at least equal to such proportions as they own or control as of the date of this Lease; (3) the Partners (or their \u201cPermitted Transferees\u201d, as such term is defined under the Limited Partnership Agreement) comprising Tenant cease to maintain their Percentage Interests in the Tenant under this Lease in the same proportions as they exist as of the date of this Lease, except (a) as such Percentage Interests may be adjusted pursuant to the Limited Partnership Agreement as a result of a capital contribution made under Section 4.2 of the Limited Partnership Agreement by one of the Partners, (b) as portions of such Percentage Interests may be assigned by the \u2587\u2587\u2587\u2587\u2587\u2587 Entities with the consent of \u2587\u2587\u2587\u2587\u2587\u2587, or (c) as Landlord\u2019s Percentage Interest may be reduced pursuant to the call right contained in Section 4.8 of the Limited Partnership Agreement as a result of a termination by Landlord of his Employment Agreement without \u201cGood Reason\u201d as defined therein, or (4) in the event Tenant establishes a Newco to hold the REIT shares attributable to the transfer of the Property to the REIT, such Newco fails to have the same ownership structure as the Limited Partnership as of the date of the creation of Newco except (a) as such ownership structure may be adjusted in a manner similar to the adjustment of Percentage Interests under the Limited Partnership Agreement as a result of a capital contribution made under a provision similar to Section 4.2 of the Limited Partnership Agreement by one of the Partners, (b) as portions of such interests similar to Percentage Interests may be assigned by the \u2587\u2587\u2587\u2587\u2587\u2587 Entities with the consent of \u2587\u2587\u2587\u2587\u2587\u2587, or (c) as Landlord\u2019s Percentage Interest may be reduced pursuant to a call right similar to the one contained in Section 4.8 of the Limited Partnership Agreement as a result of a termination by Landlord of his Employment Agreement without \u201cGood Reason\u201d as defined therein.", "size": 3, "samples": [{"hash": "2rSG0Fs0j13", "uri": "/contracts/2rSG0Fs0j13#reversion-event", "label": "Lease Agreement", "score": 31.3408622742, "published": true}, {"hash": "jS0U4cysezO", "uri": "/contracts/jS0U4cysezO#reversion-event", "label": "Lease Agreement (Asbury Automotive Group Inc)", "score": 21.0, "published": true}], "snippet_links": [{"key": "purchase-of-the-property", "type": "clause", "offset": [82, 106]}, {"key": "option-event", "type": "clause", "offset": [119, 131]}, {"key": "in-the-event-of-a", "type": "clause", "offset": [136, 153]}, {"key": "option-to", "type": "clause", "offset": [170, 179]}, {"key": "giving-of-notice", "type": "clause", "offset": [213, 229]}, {"key": "pursuant-to-section", "type": "definition", "offset": [230, 249]}, {"key": "prior-to-an-ipo", "type": "clause", "offset": [263, 278]}, {"key": "the-contemplated", "type": "clause", "offset": [284, 300]}, {"key": "to-sell", "type": "clause", "offset": [312, 319]}, {"key": "shares-of", "type": "clause", "offset": [327, 336]}, {"key": "the-reit", "type": "clause", "offset": [337, 345]}, {"key": "to-the-public", "type": "definition", "offset": [346, 359]}, {"key": "the-purchase-transaction", "type": "clause", "offset": [445, 469]}, {"key": "subsequent-to-the", "type": "clause", "offset": [509, 526]}, {"key": "calendar-year", "type": "definition", "offset": [527, 540]}, {"key": "own-or-control", "type": "definition", "offset": [634, 648]}, {"key": "the-tenant", "type": "clause", "offset": [649, 659]}, {"key": "at-least-equal-to", "type": "definition", "offset": [675, 692]}, {"key": "date-of-this-lease", "type": "definition", "offset": [743, 761]}, {"key": "the-partners", "type": "definition", "offset": [767, 779]}, {"key": "permitted-transferees", "type": "definition", "offset": [791, 812]}, {"key": "limited-partnership-agreement", "type": "clause", "offset": [849, 878]}, {"key": "to-maintain", "type": "clause", "offset": [904, 915]}, {"key": "under-this-lease", "type": "clause", "offset": [957, 973]}, {"key": "pursuant-to-the", "type": "definition", "offset": [1098, 1113]}, {"key": "capital-contribution", "type": "clause", "offset": [1161, 1181]}, {"key": "section-42", "type": "clause", "offset": [1193, 1204]}, {"key": "the-\u2587", "type": "clause", "offset": [1330, 1335]}, {"key": "consent-of", "type": "clause", "offset": [1359, 1369]}, {"key": "as-landlord", "type": "definition", "offset": [1385, 1396]}, {"key": "the-call-right", "type": "clause", "offset": [1446, 1460]}, {"key": "contained-in", "type": "definition", "offset": [1461, 1473]}, {"key": "section-48", "type": "clause", "offset": [1474, 1485]}, {"key": "termination-by-landlord", "type": "definition", "offset": [1540, 1563]}, {"key": "employment-agreement", "type": "definition", "offset": [1571, 1591]}, {"key": "good-reason", "type": "definition", "offset": [1601, 1612]}, {"key": "reit-shares", "type": "definition", "offset": [1693, 1704]}, {"key": "transfer-of-the-property", "type": "clause", "offset": [1725, 1749]}, {"key": "ownership-structure", "type": "definition", "offset": [1797, 1816]}, {"key": "similar-to", "type": "definition", "offset": [1951, 1961]}, {"key": "adjustment-of-percentage-interests", "type": "clause", "offset": [1966, 2000]}, {"key": "pursuant-to-a", "type": "definition", "offset": [2375, 2388]}], "hash": "34ba1d6704646e630c03e415d0a1ad97", "id": 4}, {"snippet": "means any of the following: (a) KAVL or Kaival Labs declaring bankruptcy or making an assignment for the benefit of its creditors; (b) Kaival Labs fails to develop a Covered Product by October 31, 2023, unless Kaival Labs is actively engaged in obtaining FDA approval of a Covered Product as set forth in Section 2.3(iv); (c) Kaival Labs is denied FDA approval as set forth in Section 2.3(iv) of this Agreement unless Kaival Labs develops a Covered Product unrelated to FDA approval as set forth in Section 2.3(v) of this Agreement; or (d) KAVL or Kaival Labs materially breaches this Agreement after NGL provides written notice of such material breach to KAVL by signature delivery and the material breach is not cured within fifteen (15) Business Days after delivery of the material breach written notice. For the avoidance of doubt, a Reversion Event cannot occur if: (y) Kaival Labs is actively seeking FDA approval; or (z) Kaival Labs has produced, or is producing, any Covered Product.", "size": 2, "samples": [{"hash": "99vxiP4rti3", "uri": "/contracts/99vxiP4rti3#reversion-event", "label": "Patent Contribution Agreement (Kaival Brands Innovations Group, Inc.)", "score": 31.7405891418, "published": true}, {"hash": "6pbn2lCZudv", "uri": "https://dd7pmep5szm19.cloudfront.net/2430/0001731122-20-001000.pdf", "label": "dd7pmep5szm19.cloudfront.net", "score": 10.3702945709, "published": false}], "snippet_links": [{"key": "declaring-bankruptcy", "type": "clause", "offset": [52, 72]}, {"key": "an-assignment", "type": "definition", "offset": [83, 96]}, {"key": "for-the-benefit-of", "type": "definition", "offset": [97, 115]}, {"key": "to-develop", "type": "definition", "offset": [153, 163]}, {"key": "covered-product", "type": "clause", "offset": [166, 181]}, {"key": "by-october", "type": "clause", "offset": [182, 192]}, {"key": "engaged-in", "type": "definition", "offset": [234, 244]}, {"key": "approval-of", "type": "clause", "offset": [259, 270]}, {"key": "this-agreement", "type": "clause", "offset": [396, 410]}, {"key": "notice-of", "type": "definition", "offset": [622, 631]}, {"key": "material-breach", "type": "definition", "offset": [637, 652]}, {"key": "the-material", "type": "definition", "offset": [687, 699]}, {"key": "delivery-of-the", "type": "clause", "offset": [760, 775]}, {"key": "for-the-avoidance-of-doubt", "type": "clause", "offset": [808, 834]}, {"key": "actively-seeking", "type": "definition", "offset": [890, 906]}], "hash": "434f953f5af7c420b35f027fee9fe912", "id": 5}, {"snippet": "means, following the occurrence of a Suspension Period, Holdings no longer maintains at least two of the ratings specified in the definition of Suspension Period.", "size": 2, "samples": [{"hash": "cCEflR4SzbD", "uri": "/contracts/cCEflR4SzbD#reversion-event", "label": "Credit Agreement (Western Digital Corp)", "score": 25.0219020844, "published": true}, {"hash": "iykjVeoHkY", "uri": "https://investor.wdc.com/index.php/static-files/c3e2d654-d33a-4892-8295-ada8370d03a6", "label": "investor.wdc.com", "score": 7.96235466, "published": false}], "snippet_links": [{"key": "following-the", "type": "definition", "offset": [7, 20]}, {"key": "suspension-period", "type": "definition", "offset": [37, 54]}, {"key": "the-definition-of", "type": "clause", "offset": [126, 143]}], "hash": "7b4b43f18c6cf011bc9959b23882fa6c", "id": 6}, {"snippet": "means (i) the termination or non-renewal of the Advisory Agreement or (ii) \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587. \u2587\u2587\u2587\u2587\u2587\u2587\u2019\u2587 resignation as the Chief Executive Officer and director of \u2587\u2587\u2587\u2587\u2587\u2587\u2587 and the Advisor.", "size": 1, "samples": [{"hash": "lXey4Cjb9DG", "uri": "/contracts/lXey4Cjb9DG#reversion-event", "label": "Acquisition Agreement (Newkirk Realty Trust, Inc.)", "score": 21.0, "published": true}], "snippet_links": [{"key": "termination-or-non", "type": "clause", "offset": [14, 32]}, {"key": "agreement-or", "type": "definition", "offset": [57, 69]}, {"key": "director-of", "type": "clause", "offset": [142, 153]}], "hash": "94000fe92d030728f6c6a7c9c337d1e7", "id": 7}, {"snippet": "means a transfer of ownership of the Licensed IP from Licensor to Assignor pursuant to Sections 3.5 and 14.6A of the Assignment Agreement (i.e., following termination of the PSA due solely to an uncured Fidelion Material Breach, after all notice/cure periods and any dispute hold).", "size": 1, "samples": [{"hash": "d8FT8SpJNz4", "uri": "/contracts/d8FT8SpJNz4#reversion-event", "label": "Exclusive Intellectual Property License Agreement (BioNexus Gene Lab Corp)", "score": 36.9178644764, "published": true}], "snippet_links": [{"key": "ownership-of-the", "type": "clause", "offset": [20, 36]}, {"key": "licensed-ip", "type": "definition", "offset": [37, 48]}, {"key": "pursuant-to-sections", "type": "clause", "offset": [75, 95]}, {"key": "assignment-agreement", "type": "clause", "offset": [117, 137]}, {"key": "termination-of-the", "type": "clause", "offset": [155, 173]}, {"key": "material-breach", "type": "definition", "offset": [212, 227]}, {"key": "cure-periods", "type": "definition", "offset": [246, 258]}], "hash": "acaef2241a99a45cfbad73a1567e2f15", "id": 8}, {"snippet": "means the occurrence of circumstances in which (after notice and an opportunity to cure for thirty (30) days in the case of clauses (ii) and (iii) below), (i) AG.C\u2587\u2587 has less than 10% of its revenues derive from the AG.C\u2587\u2587 Business; (ii)", "size": 1, "samples": [{"hash": "a0MzhKrNvei", "uri": "/contracts/a0MzhKrNvei#reversion-event", "label": "Cross License Agreement (Americangreetings Com Inc)", "score": 18.0, "published": true}], "snippet_links": [{"key": "after-notice", "type": "definition", "offset": [48, 60]}, {"key": "opportunity-to-cure", "type": "clause", "offset": [68, 87]}, {"key": "in-the-case", "type": "clause", "offset": [109, 120]}], "hash": "e78eeb4a75c18383969afabf4b774b47", "id": 9}, {"snippet": "means, with respect to a Pledged Foreign Subsidiary, a determination, in the sole discretion of the Board of Directors, that the continued existence of a pledge of more than 65% of the outstanding Capital Stock entitled to vote would result in a material adverse tax consequence to the Company or a regarded Person (for U.S. federal tax purposes) that owns Capital Stock in the Company.", "size": 1, "samples": [{"hash": "f0yuQJJy7Sh", "uri": "/contracts/f0yuQJJy7Sh#reversion-event", "label": "Indenture (Roth CH Acquisition I Co. Parent Corp.)", "score": 31.8856945038, "published": true}], "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "pledged-foreign-subsidiary", "type": "definition", "offset": [25, 51]}, {"key": "the-board-of-directors", "type": "definition", "offset": [96, 118]}, {"key": "continued-existence", "type": "clause", "offset": [129, 148]}, {"key": "outstanding-capital-stock", "type": "definition", "offset": [185, 210]}, {"key": "entitled-to-vote", "type": "definition", "offset": [211, 227]}, {"key": "adverse-tax-consequence", "type": "definition", "offset": [255, 278]}, {"key": "to-the-company", "type": "clause", "offset": [279, 293]}, {"key": "for-us", "type": "clause", "offset": [316, 323]}, {"key": "federal-tax-purposes", "type": "clause", "offset": [325, 345]}], "hash": "a54bd38ccb1e8ca4b2f9a09f044eb5f1", "id": 10}], "next_curs": "ClwSVmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjgLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIYcmV2ZXJzaW9uLWV2ZW50IzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "shall exist in the event that Purchaser, itself or through one or more of its Affiliates, licensees and sublicensees, (i) fails to satisfy the NDA Requirement, or (ii) in the reasonable judgment of APIL, fails to comply with its Commercially Reasonable Efforts requirements under Section 3.1 of this Exhibit D; provided that, any such failure is not attributable to the material breach by APIL or any of its Affiliates of any of the Ancillary Agreements, which material breach was noticed by Purchaser prior to its receipt of a Reversion Notice from APIL under this Section 4.1.\n(A) In the event the failure to satisfy the NDA Requirement is the result of a change in the FDA\u2019s policies or procedures regarding the approval of the Earn-Out Product or drugs in the same class as the Earn-Out Product, and Purchaser, its Affiliates, licensees or sublicensees have used Commercially Reasonable Efforts to accommodate such change and were still unable to satisfy the NDA Requirement, then the deadline shall be extended for a reasonable period of time, but not more than three-hundred sixty-five (365) calendar days or such longer period of time as determined by APIL in good faith based on the impact of such change in the FDA\u2019s policies or procedures on their ability to accommodate such change in policies or procedures.\n(B) In the event the failure to satisfy the NDA Requirement is the result of other delays or circumstances that are outside of the reasonable control of Purchaser or its Affiliates, licensees and sublicensees, and Purchaser, its Affiliates, licensees or sublicensees have used Commercially Reasonable Efforts consistent with Section 3.1 of this Exhibit D to overcome such delay or circumstance, then APIL will reasonably consider extending the deadline for a reasonable period of time, but not more than three-hundred sixty-five (365) days, to overcome such failure. In each case of (A) or (B), the compliance with such new deadline shall remain an obligation of Purchaser, its Affiliates, licensees or sublicensees subject to their diligence efforts under Section 3.1 of this Exhibit D and APIL\u2019s rights under this Section 4.1(a).", "size": 34, "title": "Reversion Event", "id": "reversion-event", "examples": ["The Trustee shall have no duty to monitor the ratings of the Notes, monitor the occurrence of a Covenant Suspension Event or <strong>Reversion Event</strong> or notify Holders of the same.", "If a <strong>Reversion Event</strong> occurs, the Parties agree to work in good faith to determine the impact of such <strong>Reversion Event</strong> and the best then applicable index to be used for the Covered Transactions; provided, however, that if the Parties are not able to timely agree on the applicable index, then the ICE Day-Ahead Power Price for the SP15 Zone or NP15 Zone (as appropriate) shall be the applicable index until the <strong>Reversion Event</strong> ceases and MRTU is re-implemented.", "Notwithstanding the foregoing, if an AHI <strong>Reversion Event</strong> For Cause occurs prior to the fifth (5th) anniversary of the Effective Date, and an AHI Vesting Change of Control has not occurred prior to such time, then the Class J Incentive Units shall be forfeited in their entirety.", "Such written notice from the Securityholder Representative following a <strong>Reversion Event</strong> Trigger shall be deemed to cause a \u201cReversion\u201d to occur.", "The Parties acknowledge that any <strong>Reversion Event</strong> is not subject to the restrictions contained in this Section 14.02.", "Effective upon written notice from IBM after a <strong>Reversion Event</strong>, Finjan Blue hereby transfers and assigns to IBM all right, title and interest in and to the Assigned Patents that Finjan Blue has, including the right to \u2587\u2587\u2587 for injunctive relief and damages for infringement of any of the Assigned Patents accruing on and after the Reversion Effective Date.", "For a period of thirty (30) Business Days following the delivery of such Disagreement Notice, Purchaser and APIL shall seek in good faith to come to an agreement on the existence of the <strong>Reversion Event</strong>.", "Upon the occurrence of a <strong>Reversion Event</strong>, the Exclusivity Assignment shall immediately terminate without any further action on the part of either party and all rights assigned to Newkirk pursuant to this Agreem\u2587\u2587\u2587 \u2587\u2587\u2587 any assignment delivered in connection therewith shall revert to First Union.", "Upon a <strong>Reversion Event</strong>, the City may exercise the Reversionary Right to reacquire title to the Development Property.", "If Purchaser disagrees with APIL regarding the existence of a <strong>Reversion Event</strong>, it shall notify APIL within ten (10) Business Days of receipt of a Reversion Notice of its disagreement (such period, the \u201cChallenge Period,\u201d and such notice, a \u201cDisagreement Notice\u201d)."], "related": [["exclusion-event", "Exclusion Event", "Exclusion Event"], ["suspension-event", "Suspension Event", "Suspension Event"], ["reversion-date", "Reversion Date", "Reversion Date"], ["succession-event", "Succession Event", "Succession Event"], ["conversion-event", "Conversion Event", "Conversion Event"]], "related_snippets": [], "updated": "2025-12-04T05:48:23+00:00"}, "json": true, "cursor": ""}}